Noom and Waltz Health Collaborate on Affordable GLP-1 Weight Loss Program

Partnership:
Noom and Waltz Health have partnered to create a comprehensive and affordable weight loss program that includes GLP-1 medication management.

Program Features:

Waltz Connect:
An end-to-end solution that manages specialty medication coverage, including a dynamic marketplace with competing specialty pharmacies to reduce costs and enhance transparency.

Noom Med:
A clinical obesity management solution combining evidence-based obesity care with a behavior change program to achieve sustained weight loss while lowering employer costs.

Benefits:

Cost Reduction:
The program aims to reduce costs by bypassing traditional intermediaries and leveraging Waltz Connect’s dynamic marketplace to secure affordable prices for GLP-1 medications.

Transparency:
Employees have upfront visibility into medication costs through the Noom app, improving the medication fulfillment experience and saving employers money.

Impact:
The collaboration addresses the high cost of obesity, which is estimated to cost U.S. businesses and employees $425.5 billion annually, by making GLP-1 medications more accessible and cost-effective.

Technology:
Waltz Connect uses AI-enabled prescription routing software to find the best and most appropriate specialty pharmacy option based on specific criteria, enhancing efficiency and reducing costs.